CSBR:NASDAQ
Champions Oncology Inc
US$4,45
arrow_upward
+1,14%(+0,050) 1D
20 ພ.ຈ., 9 ໂມງ 59 ນາທີ 27 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
US$4,45
High
US$4,45
Low
US$4,45
Mkt. cap
61,94 ລ້ານ
Avg. vol.
6,97 ພັນ
Volume
4,95 ພັນ
52-wk high
US$8,31
52-wk low
US$4,40
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
Open
US$4,45
High
US$4,45
Low
US$4,45
Mkt. cap
61,94 ລ້ານ
Avg. vol.
6,97 ພັນ
Volume
4,95 ພັນ
52-wk high
US$8,31
52-wk low
US$4,40
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
News stories
From web sources and news partners
Barron's
·
1 ຊົ່ວໂມງກ່ອນ
S&P 500 Skid Enters Seventh Day as Dow Nears Correction
Coinpaper
·
1 ຊົ່ວໂມງກ່ອນ
S&P 500 Price Prediction: S&P 500 Falls 2.3% Below 200-Day Average
ChartMill
·
2 ຊົ່ວໂມງກ່ອນ
S&P 500 Premarket Movers Friday: Gainers and Losers
marketscreener.com
·
3 ຊົ່ວໂມງກ່ອນ
Societe Generale sees S&P 500 ending 2027 at 8,500 on AI, earnings support
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ນິວເຈີຊີ, ສະຫະລັດ
SectorHealth Care
Industry-
Websitechampionsoncology.com